疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

. z) F$ K8 |$ u" ]" d$ o

Vaccines, 6th Edition

1 W3 F% h) B9 j$ e* X7 tApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
* n* w. c& n  k  F. y; L% }
http://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
7 d: ~8 w$ I, g- L
& f- f# {9 ~# d/ e& aSECTION 1: General aspects of vaccination
' D6 k3 Y- g, Z8 N: \) R# K/ D1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
& k/ P6 Y7 s+ R# Nlicensed vaccines 71
# k; u; [4 F" u; W7 Q3 b' `7 ]# \7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
9 O; d9 r9 d& z; U: f10 Anthrax vaccines 127
11 Cholera vaccines 141
. A2 h5 i5 }! Y) Y- ^! H. k5 ~( }$ i12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
/ x% ?0 k& J' e8 n! @14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
5 g' Z6 f2 J$ d; \; j6 V, d17 Inactivated influenza vaccines 257
' m. r( w4 J, [7 u( n18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
3 O2 R0 e0 K' M- _( s22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
# k9 Y2 z# Q, ^. E2 a# \0 C30 Rotavirus vaccines . 669
31 Rubella vaccine 688
' J/ p  c) d  n# U) Y1 q/ H32 Smallpox and vaccinia 718
# P3 q- d$ v8 ~: l$ S: l6 A/ q2 z33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
1 h" k% ^( `7 b42 Therapeutic cancer vaccines 1018
6 n+ H5 c) `  V5 z* j. M, k- T9 }43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
- O5 L- _7 |4 E2 t( a0 R45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
7 G: \; m0 t" Y9 ~1 F48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
: i$ J6 G% T6 k* d: s5 X50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
) F& T8 Q, j/ T$ I5 r+ _( Z2 z4 I% ]52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
0 J1 M- S& x, Q' u7 ]55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
& q% ~5 e' T) `' z# j" t+ h56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
9 q3 P7 \1 O7 }5 K5 f6 h62 The development of gene-based vectors for immunization 1232
# f' G' p( B* I+ mSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
2 l. e, C( y  U: ]; A* q$ W4 D7 i64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
9 q" O2 L8 r4 W67 Immunization in the United States 1310
68 Immunization in Europe . 1334
) a/ ^, _3 |5 K- K% u- P69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
% O* U* {% B( V; h5 \7 j73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
0 ?2 G  B( U: Q5 J3 \: k# d77 Legal issues . 1481
- P; U9 U, Q- b; Y. M78 Ethics 1508

/ ?0 N" i" t- n1 _5 ]
. m# n( M" v3 \' P
0 Q. `3 E: d0 W8 N
7 U# e& W. J2 U

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

& X( s* g7 @& o4 R( H( IVaccines, 6th Edition
- D( P8 Q7 y8 G% K& D
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

3 O" L# }: A1 u' phttp://yun.baidu.com/share/link? ... 1&uk=3810996606
; g6 @; y: F, f" D. ?" X
SECTION 1: General aspects of vaccination
$ `" i/ w& R! s- {: ~. e1 A short history of vaccination 1
. [7 x! U$ I: E: t, n2 Vaccine immunology 14
3 The vaccine industry 33
) \/ j; A1 H2 e& n4 Vaccine manufacturing 44
. l! j4 m5 [+ u( A5 Evolution of adjuvants across the centuries 58
6 Y; V6 w2 J9 K% u6 Vaccine additives and manufacturing residuals in the United States:
5 F5 [$ Q1 D* W; l6 k: f6 b& ^licensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
2 m8 a$ Q4 q7 j0 F10 Anthrax vaccines 127
5 ?3 }; _( W' z: a- A7 M11 Cholera vaccines 141
12 Diphtheria toxoid 153
& [; l/ i' Q, [8 D7 B13 Haemophilus influenzae vaccines 167
+ D6 `0 f6 U1 a: F- d14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
5 X1 ~/ t+ e# }5 v. Q% j& {. a# Y16 Human papillomavirus vaccines 235
: p" x. b: i+ }17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
  O4 f- b% ~6 b! ]& x+ u21 Meningococcal vaccines 388
1 f$ w2 w( t; {% j: P0 R22 Mumps vaccine 419
0 G) F" w: r" a9 _. c1 n23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
# n& u7 ?; ?* X: \28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
) [9 m% J+ ~$ I3 [3 ~31 Rubella vaccine 688
; ^* l9 W3 x; B* q9 R+ b32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
# d" \- G7 o+ [/ T36 Typhoid fever vaccines 812
+ z* y0 A% h! t37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
2 b3 F7 X5 f0 E40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
1 h/ Y& h2 I% }) b& J- o41 Biodefense and special pathogen vaccines 1008
8 \. a1 L8 j# x$ l1 ]# j42 Therapeutic cancer vaccines 1018
9 L2 J6 N- _9 e% @6 M3 k43 Cytomegalovirus vaccines 1032
. ]$ W# p9 [& g! ~$ x6 j$ \, v( S44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
! Q3 \& ~0 D. y9 T' C46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
  f, }' k) u" Z1 `0 n+ C+ y7 p48 Hepatitis C vaccines 1074
1 l! r/ r9 S* I8 g4 v49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
* j+ N3 Q9 Z" k' d51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
5 ~! |. ?  Q  c8 b55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
/ B+ E8 w( o( |56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
, e" y8 ^5 W9 _1 n' K58 Streptococcus group A vaccines 1169
: S- G. z6 F; o% ?59 Streptococcus group B vaccines 1176
6 P7 {$ M7 v0 I) h" @5 ^1 p60 Technologies for making new vaccines 1182
$ _* |8 W% {2 L5 N4 L; v7 I61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
* g1 I, @# O' o63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
0 x9 D) i1 Q' X8 I9 {66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
% Q% ~. h9 G! \/ S9 C( y) m71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
1 [& E8 f2 r7 Z/ M9 ~% A3 j- C, F/ ~74 Regulation of vaccines in Europe 1447
! R9 v0 d3 s" j75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508

casarett

Vaccines, 6e, 2012
* q: X. R  c$ Q
Hardcover: 1570 pages
Publisher: Saunders; 6 edition (October 30, 2012)
) F( o+ J0 u8 Q1 \Language: English
ISBN-10: 1455700908
Size: 52.3mb (original pdf)

1 n1 U5 T# l( Y5 _. z2013 BMA Medical Book Awards Highly Commended in Public Health!
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

) ~0 B! w" u; a$ |Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
! ~! i) Z; h0 s5 O+ |0 TUpdate your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
7 S- ~$ o" O; v! y8 T3 g& UAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
* Z! t  q; D. ~/ A4 NClearly visualize concepts and objective data through an abundance of tables and figures.
5 V. M7 i- ?0 S4 @; J, @Perform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
! w. E( s5 D* O! b" g0 p/ A
Download link: http://pan.baidu.com/s/1i5NxwLR
6 M+ N" R9 K' |Code for downloading: dv96
- {0 ^# F; p6 t! l. i2 q# _! |